Balancing these tools with operational efficiencies can aid CROs in meeting the evolving needs of sponsors.
Guillaume Gigon
Advertisement
VP of Technology and AI, Innovaderm
Articles by Guillaume Gigon
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior License Execution Would Significantly Benefit Clinical Trial Set-Up
2
Moving Beyond Historical Site Data to Real-Time Patient Insight
3
Why Trial Competition Is Undermining AI-Driven Gains
4
ACT Brief: Trial Competition Slows AI Gains, Rethinking Patient-Level Safety Decisions, and What Separates Real AI Platforms in Clinical Trials
5